Comparison of Marketing Authorization System for Drug Wholesale Enterprises between China and America

Ke Rong,Shao Rong

DOI: https://doi.org/10.3969/j.issn.1002-7777.2012.05.001

2012-01-01

Abstract:Objective To improve the marketing authorization system for domestic drug wholesale enterprises in China.Methods Comparison was performed between American and domestic marketing authorization system for drug wholesale enterprises in terms of examining procedures and contents.Results The domestic marketing authorization system has following disadvantages as putting more emphasis on approval while lacking post-approval management,redundant examining procedures resulting in low administrative efficiency,emphasizing hardware requirements but neglect impotance for credit check.Conclusion The regulatory authorities should merge the GSP regulation into the examining of the Drug Supply Certificate,turn the GSP certification into follow-up inspections,and enhance the regulation of the sale and purchase records provider.